Citation

Schoepfer J, Jahnke W, Berellini G, Buonamici S, Cotesta S, Cowan-Jacob SW, Dodd S, Drueckes P, Fabbro D, Gabriel T, Groell JM, Grotzfeld RM, Hassan AQ, Henry C, Iyer V, Jones D, Lombardo F, Loo A, Manley PW, Pellé X, Rummel G, Salem B, Warmuth M, Wylie AA, Zoller T, Marzinzik AL, Furet P.: Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. J Med Chem, Volume 61 (18), 2018

Authors

Berellini G, Buonamici S, Cotesta S, Cowan-Jacob SW, Dodd S, Drueckes P, Fabbro D, Furet P., Gabriel T, Groell JM, Grotzfeld RM, Hassan AQ, Henry C, Iyer V, Jahnke W, Jones D, Lombardo F, Loo A, Manley PW, Marzinzik AL, Pellé X, Rummel G, Salem B, Schoepfer J, Warmuth M, Wylie AA, Zoller T

Journal

J Med Chem

Year

2018

DOI

10.1021/acs.jmedchem.8b01040

PubMed

30137981

Machine-readable

REST APIRDF